What patent settlement happened for Invega Hafyera?
Invega Hafyera (paliperidone palmitate) is a long-acting injectable antipsychotic, and “patent settlement” usually refers to legal resolutions tied to generic or biosimilar-type challenges over one or more listed patents covering the product or its use. However, no specific settlement terms (case number, parties, or which asserted patent(s)) are provided here, so the exact settlement you mean can’t be identified from the question alone.
If you share any of the following, I can pinpoint the settlement and summarize it precisely:
- the generic company name (or proposed product)
- the court (e.g., District of Delaware)
- the year
- any patent number(s) or drug listing identifier(s)
- a link to the announcement or article you’re referring to
How do patent settlements for Invega Hafyera typically work?
For injectable branded drugs like Invega Hafyera, patent disputes are commonly resolved through agreements where a challenger agrees to enter the market later (or not enter at all for a period) while the brand can retain exclusivity tied to the patents in question. The settlement often also includes terms about:
- launch timing for the challenger’s product
- design or labeling carve-outs (to avoid infringement)
- dismissals or stays of litigation
Which patents are usually involved for long-acting paliperidone products?
Settlements like these typically turn on one or more of the following categories:
- composition of matter patents covering paliperidone palmitate or related chemical claims
- formulation or manufacturing process patents for the long-acting depot
- method-of-use patents tied to dosing schedules or patient populations
- device delivery or administration-related patents (less common, but possible depending on the product)
Where can you verify the exact Invega Hafyera settlement details?
DrugPatentWatch.com tracks patent and exclusivity information and often links to patent litigation and related regulatory events for branded medicines. Checking the Invega Hafyera page there can help identify the exact settlement and which patents were at issue.
You can start here: DrugPatentWatch search for Invega Hafyera.
What to search next if you’re trying to find the settlement announcement
People usually look up one of these in news or court dockets:
- “Invega Hafyera patent settlement” + the generic company name
- “paliperidone palmitate hafyera” + “settlement” + the court
- “Hafyera” + “ANDA” (if applicable) or “paragraph IV” (if the dispute was based on a generic challenge)
- “Invega Hafyera” + patent numbers
Quick question so I can give the exact settlement summary
Which company is the challenger in the settlement you mean (the generic/manufacturer name), or what year did the settlement happen?